Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.

BLACU

Bellevue Life Sciences A... (BLACU)

Bellevue Life Sciences Acquisition Corporation
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:BLACU
일자시간출처헤드라인심볼기업
2024/02/2206:20Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BLACUBellevue Life Sciences Acquisition Corporation
2024/02/1323:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BLACUBellevue Life Sciences Acquisition Corporation
2024/02/0906:20Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:BLACUBellevue Life Sciences Acquisition Corporation
2024/02/0603:48Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:BLACUBellevue Life Sciences Acquisition Corporation
2023/11/1707:00PR Newswire (US)OSR Holdings Co., Ltd. Enters Into Business Combination Agreement with Bellevue Life Sciences Acquisition Corp.NASDAQ:BLACUBellevue Life Sciences Acquisition Corporation
2023/11/1706:37Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:BLACUBellevue Life Sciences Acquisition Corporation
2023/11/1706:35Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BLACUBellevue Life Sciences Acquisition Corporation
2023/11/1520:04Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BLACUBellevue Life Sciences Acquisition Corporation
2023/11/0806:20Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:BLACUBellevue Life Sciences Acquisition Corporation
2023/10/2105:20Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:BLACUBellevue Life Sciences Acquisition Corporation
2023/10/1106:00Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:BLACUBellevue Life Sciences Acquisition Corporation
2023/08/1505:45Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:BLACUBellevue Life Sciences Acquisition Corporation
2023/07/1205:58Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:BLACUBellevue Life Sciences Acquisition Corporation
2023/07/1205:56Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BLACUBellevue Life Sciences Acquisition Corporation
2023/07/1205:45PR Newswire (US)Bellevue Life Sciences Acquisition Corp. and OSR Holdings Sign an Exclusive Letter of Intent for a Business CombinationNASDAQ:BLACUBellevue Life Sciences Acquisition Corporation
2023/06/2905:50Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BLACUBellevue Life Sciences Acquisition Corporation
2023/06/1506:01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BLACUBellevue Life Sciences Acquisition Corporation
2023/05/2305:35Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:BLACUBellevue Life Sciences Acquisition Corporation
2023/05/1621:01Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)NASDAQ:BLACUBellevue Life Sciences Acquisition Corporation
2023/04/0105:20Edgar (US Regulatory)Annual Report (10-k)NASDAQ:BLACUBellevue Life Sciences Acquisition Corporation
2023/03/2805:10Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BLACUBellevue Life Sciences Acquisition Corporation
2023/03/2805:07Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BLACUBellevue Life Sciences Acquisition Corporation
2023/03/2805:04Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BLACUBellevue Life Sciences Acquisition Corporation
2023/03/1505:16Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BLACUBellevue Life Sciences Acquisition Corporation
2023/03/1505:05PR Newswire (US)Bellevue Life Sciences Acquisition Corp. Announces Separate Trading of its Shares of Common Stock, Warrants and Rights Commencing March 17, 2023NASDAQ:BLACUBellevue Life Sciences Acquisition Corporation
2023/03/0107:37Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BLACUBellevue Life Sciences Acquisition Corporation
2023/02/2406:37Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BLACUBellevue Life Sciences Acquisition Corporation
2023/02/2206:05PR Newswire (US)Bellevue Life Sciences Acquisition Corp. Announces Closing of Full Over-allotment OptionNASDAQ:BLACUBellevue Life Sciences Acquisition Corporation
2023/02/1506:05PR Newswire (US)Bellevue Life Sciences Acquisition Corp. Announces Closing of $60 Million Initial Public OfferingNASDAQ:BLACUBellevue Life Sciences Acquisition Corporation
 검색 관련기사 보기:NASDAQ:BLACU